The independent source for health policy research, polling, and news.
41 - 60 of 112,370 Results
The 2025 Affordability Survey released by the Commonwealth Fund shows that 63% of those who experienced a prior authorization denial said that it caused significant worry or anxiety, while 41% said it led to delays in care for them or someone in their household, Fierce Healthcare reported.
Wednesday's executive order turns about 8,000 federal workers into at-will employees, NPR reported, which allows the government to fire them without giving a reason. Nearly all of those affected are at the GS-15 level, the highest possible pay grade that includes high-level policy staff. In other administration news: The VA has changed how it buys prosthetic limbs, which could speed their delivery to veterans.
The New World screwworm fly's larvae feed on the tissue of livestock, wildlife, and pets. A case has been confirmed in a 3-week-old calf in La Pryor, Texas, The New York Times reported. Plus: updates on Ebola, brucellosis, hantavirus, and covid.
Today's early morning highlights from the major news organizations.
Opinion writers delve into these topics and others.
Hospitals must assign one nurse for every six patients in adult psychiatric units, and one nurse for every five adolescent patients, the San Francisco Chronicle reported. Hospitals that violate the rule can be fined $15,000 to $30,000 per day. Also: New SNAP work requirements take effect in Washington, D.C.
The new rule strips the "professional degree" designation from graduate nursing students, a move that caps what they may borrow to $20,500 annually or $100,000 in aggregate, MedPage Today reports. The lawsuit argues that this exclusion is unlawful and violates the Administrative Procedure Act.
Democrat Xavier Becerra, a former U.S. health secretary, and Republican Steve Hilton were neck-and-neck Wednesday morning, but full results could take many days or weeks. In other government news, the U.S. House of Representatives approved a major increase in benefits for some of the nation's most catastrophically disabled veterans, Military.com reported.
The government is looking to assess the advanced cyber capabilities of AI models ahead of their full release to the public in an attempt to benchmark the process, CNBC reports. Plus: weight-loss drugs and cancer prevention; genetic therapies for brain disease research; and more.
According to The New York Times, Secretary of State Marco Rubio has indicated that the United States may resume funding of Gavi, a global vaccines alliance that provides immunizations for low-income nations. Gavi maintains the global Ebola vaccine stockpile. Health Secretary Robert F. Kennedy Jr. has blocked funding for it.
Public health experts note the "medical frailty" exemption, and specifically the bureaucratic red tape it will create, will lead to even more people losing their Medicaid coverage. “This is where we’ll see large and harmful coverage losses,” one public health expert told Stat.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these topics and others.
The Washington Post reports on a previously unreleased settlement agreement between Texas Attorney General Ken Paxton, a Republican, and the Houston hospital, which is the nation’s largest pediatric hospital. The clinic will provide surgery, fertility counseling, and therapy, among other services. Also: About 374,000 Californians canceled their Covered California marketplace health coverage during the first quarter of the year.
The message went out to about 50 hospitals, Stat reports, and comes as part of the company's effort to reduce what it calls duplicate discounts paid to participating hospitals. Other industry news is on pediatric prior authorization, telehealth, autism therapy, and more.
Florida’s lawsuit claims OpenAI and CEO Sam Altman prioritized commercial gain over user safety. Experts both inside and outside the company repeatedly warned about the dangers of the product that facilitates and encourages self-harm and violence, AP wrote.
FiercePharma reports on how Shionogi’s oral antiviral drug — sold under the name Xocova and available in Japan since 2022 — has been cleared by the FDA for post-exposure prophylaxis for U.S. adults and some adolescents who have been exposed to covid. This makes it the first post-exposure covid oral drug approved in the United States.
The Bundibugyo strain of the Ebola virus has no targeted vaccine or therapeutics, CIDRAP reports. Experts say that the outbreak, which is already the third-largest in history, is likely much worse than official numbers suggest.
The guidance to states indicates pregnant women, parents of young children, veterans with disabilities, and people who are “medically frail” are among the Medicaid enrollees who may be exempt from work requirements, but not people who are homeless, NBC reports. Also: The Trump administration has been blocked from removing currently enlisted transgender service members.
© 2026 KFF